{"id":387564,"date":"2026-03-16T07:41:18","date_gmt":"2026-03-16T07:41:18","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/387564\/"},"modified":"2026-03-16T07:41:18","modified_gmt":"2026-03-16T07:41:18","slug":"oracles-ai-just-reclaimed-200000-hours-for-doctors","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/387564\/","title":{"rendered":"Oracle&#8217;s AI Just Reclaimed 200,000 Hours For Doctors"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\"><strong>Oracle Corp.<\/strong> shares surged Wednesday after the software giant reported better-than-expected third-quarter results and issued upbeat revenue guidance, while also unveiling a new clinical AI tool designed to streamline hospital documentation.<\/p>\n<p class=\"yf-1fy9kyt\">On Tuesday, Oracle posted third-quarter revenue of $17.19 billion, beating analyst estimates of $16.91 billion, according to Benzinga Pro. Adjusted earnings grew 21% year-over-year to $1.79 per share, beating analyst estimates of $1.71 per share.<\/p>\n<p class=\"yf-1fy9kyt\">Oracle expects fourth-quarter revenue to grow 18% to 20% on a year-over-year basis, roughly in line with estimates. It sees adjusted earnings per share of $1.96 and $2.00 in the fourth quarter, versus estimates of $1.95.<\/p>\n<p class=\"yf-1fy9kyt\">Several analysts made several updates to their ratings and price targets.<\/p>\n<p class=\"yf-1fy9kyt\"><strong>Don&#8217;t Miss:<\/strong><\/p>\n<p class=\"yf-1fy9kyt\">Separately, the company said on Wednesday its <a href=\"https:\/\/www.benzinga.com\/pressreleases\/26\/03\/n51185528\/oracle-health-clinical-ai-agent-helps-emergency-and-inpatient-doctors-spend-more-time-on-patient-c?nid=51260362&amp;utm_campaign=partner_feed&amp;utm_content=site&amp;utm_medium=partner_feed&amp;utm_source=yahooFinance\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" rel=\"sponsored nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Oracle Health Clinical AI Agent;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Oracle Health Clinical AI Agent&quot;,&quot;yHasCommerce&quot;:false}\" class=\"link \">Oracle Health Clinical AI Agent<\/a> for automated note generation is now available in U.S. emergency departments and inpatient settings.<\/p>\n<p class=\"yf-1fy9kyt\">The tool automatically drafts clinical notes by capturing real-time patient interactions and pulling data from the Oracle Health Foundation electronic health record, including triage notes, lab results, and imaging information. Clinicians can review, edit, and finalize the notes.<\/p>\n<p class=\"yf-1fy9kyt\">Healthcare systems are already reporting efficiency gains. AtlantiCare expanded the tool across its emergency departments after earlier deployments reduced documentation time by 41%.<\/p>\n<p class=\"yf-1fy9kyt\">\u201cJust as we saw in our ambulatory settings, we\u2019re now seeing that same impact in the emergency department,\u201d said<strong> Jordan Ruch<\/strong>, chief information officer at AtlantiCare.<\/p>\n<p class=\"yf-1fy9kyt\">Oracle said the AI system has saved physicians more than 200,000 hours across U.S. providers since launching just over a year ago.<\/p>\n<p class=\"yf-1fy9kyt\"><strong>Trending:\u00a0Own the Characters, Not Just the Content: <a href=\"https:\/\/www.benzinga.com\/money\/elf-labs-ip?nid=51260362&amp;utm_campaign=partner_feed&amp;utm_content=site&amp;utm_medium=partner_feed&amp;utm_source=yahooFinance\" rel=\"sponsored nofollow noopener\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" target=\"_blank\" data-ylk=\"slk:Inside a Fast-Growing Pre-IPO IP Company;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Inside a Fast-Growing Pre-IPO IP Company&quot;,&quot;yHasCommerce&quot;:false}\" class=\"link \">Inside a Fast-Growing Pre-IPO IP Company<\/a><\/strong><\/p>\n<p class=\"yf-1fy9kyt\">The stock is currently trading 8.5% above its 20-day simple moving average (SMA) but is 2.3% below its 50-day SMA, indicating some short-term strength while facing resistance at the 50-day level. Over the past 12 months, shares have increased by 16.38% and are currently positioned closer to their 52-week highs than lows, suggesting a bullish trend.<\/p>\n<p class=\"yf-1fy9kyt\">The RSI is at 42.87, which is considered neutral territory, while the MACD shows a value of -4.5644, with a signal line at -6.1777, indicating a bullish crossover. This combination suggests that while the stock is not currently overbought, there is potential for upward momentum.<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>Key Resistance<\/strong>: $168.50<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>Key Support<\/strong>: $138.50<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\">Oracle is expected to\u00a0provide its next financial update on June 10, 2026.<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>EPS Estimate<\/strong>: $1.64 (Down from $1.70)<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>Revenue Estimate<\/strong>: $16.90 Billion (Up from $15.90 Billion)<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>Valuation<\/strong>: P\/E of 28.1x (Indicates premium valuation)<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><strong>See Also:\u00a0This Under-$1 Pre-IPO AI Company Is Still Open to Retail Investors \u2014<a href=\"https:\/\/www.benzinga.com\/money\/immersed?nid=51260362&amp;utm_campaign=partner_feed&amp;utm_content=site&amp;utm_medium=partner_feed&amp;utm_source=yahooFinance\" rel=\"sponsored nofollow noopener\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" target=\"_blank\" data-ylk=\"slk:Learn More;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Learn More&quot;,&quot;yHasCommerce&quot;:false}\" class=\"link \"> Learn More<\/a><\/strong><\/p>\n<p class=\"yf-1fy9kyt\"><strong>Analyst Consensus &amp; Recent Actions:<\/strong> The stock carries a Buy Rating with an average price target of $251.64. Recent analyst moves include:<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>BMO Capital<\/strong>: Outperform (Lowers Target to $200.00) (Mar. 11)<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>TD Cowen<\/strong>: Buy (Maintains Target to $250.00) (Mar. 11)<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>RBC Capital<\/strong>: Sector Perform (Maintains Target to $160.00) (Mar. 11)<\/p>\n<\/li>\n<\/ul>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>iShares Expanded Tech-Software Sector ETF<\/strong> <a class=\"link \" href=\"https:\/\/www.benzinga.com\/quote\/IGV?nid=51260362&amp;utm_campaign=partner_feed&amp;utm_content=site&amp;utm_medium=partner_feed&amp;utm_source=yahooFinance\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" rel=\"sponsored nofollow noopener\" target=\"_blank\" data-ylk=\"slk:(BATS:;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;(BATS&quot;,&quot;yHasCommerce&quot;:false}\">(BATS:<\/a><a class=\"link \" href=\"http:\/\/finance.yahoo.com\/q?s=IGV\" rel=\"nofollow noopener\" data-ylk=\"slk:IGV;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;IGV&quot;}\" target=\"_blank\">IGV<\/a>): 7.37% Weight<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>First Trust NASDAQ Technology Dividend Index Fund<\/strong> <a class=\"link \" href=\"https:\/\/www.benzinga.com\/quote\/TDIV?nid=51260362&amp;utm_campaign=partner_feed&amp;utm_content=site&amp;utm_medium=partner_feed&amp;utm_source=yahooFinance\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" rel=\"sponsored nofollow noopener\" target=\"_blank\" data-ylk=\"slk:(NASDAQ:;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;(NASDAQ&quot;,&quot;yHasCommerce&quot;:false}\">(NASDAQ:<\/a><a class=\"link \" href=\"http:\/\/finance.yahoo.com\/q?s=TDIV\" rel=\"nofollow noopener\" data-ylk=\"slk:TDIV;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;TDIV&quot;}\" target=\"_blank\">TDIV<\/a>): 5.44% Weight<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><strong>Pacer Data and Digital Revolution ETF<\/strong> <a class=\"link \" href=\"https:\/\/www.benzinga.com\/quote\/TRFK?nid=51260362&amp;utm_campaign=partner_feed&amp;utm_content=site&amp;utm_medium=partner_feed&amp;utm_source=yahooFinance\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" rel=\"sponsored nofollow noopener\" target=\"_blank\" data-ylk=\"slk:(NYSE:;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;(NYSE&quot;,&quot;yHasCommerce&quot;:false}\">(NYSE:<\/a><a class=\"link \" href=\"http:\/\/finance.yahoo.com\/q?s=TRFK\" rel=\"nofollow noopener\" data-ylk=\"slk:TRFK;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;TRFK&quot;}\" target=\"_blank\">TRFK<\/a>): 9.10% Weight<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><strong>Significance:<\/strong> Because ORCL carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.<\/p>\n<p class=\"yf-1fy9kyt\"><strong>Read Next:\u00a0It\u2019s no wonder Jeff Bezos holds over $250 million in art \u2014 this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. <a href=\"https:\/\/www.benzinga.com\/money\/masterworks-blue-chip?nid=51260362&amp;utm_campaign=partner_feed&amp;utm_content=site&amp;utm_medium=partner_feed&amp;utm_source=yahooFinance\" rel=\"sponsored nofollow noopener\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" target=\"_blank\" data-ylk=\"slk:Here\u2019s how everyday investors are getting started.;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Here\u2019s how everyday investors are getting started.&quot;,&quot;yHasCommerce&quot;:false}\" class=\"link \">Here\u2019s how everyday investors are getting started.<\/a><\/strong><\/p>\n<p class=\"yf-1fy9kyt\">Photo via Shutterstock<\/p>\n<p class=\"yf-1fy9kyt\">Up Next: Transform your trading with Benzinga Edge&#8217;s one-of-a-kind market trade ideas and tools. <a href=\"https:\/\/www.benzinga.com\/premium\/ideas\/benzinga-edge-checkout\/?t=be8be9spja3yaad1&amp;utm_source=yahoo\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" rel=\"sponsored nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Click now to access unique insights;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Click now to access unique insights&quot;,&quot;yHasCommerce&quot;:false}\" class=\"link \"><strong>Click now to access unique insights<\/strong><\/a> that can set you ahead in today&#8217;s competitive market.<\/p>\n<p class=\"yf-1fy9kyt\">Get the latest stock analysis from Benzinga:<\/p>\n<p class=\"yf-1fy9kyt\">This article <a href=\"https:\/\/www.benzinga.com\/news\/26\/03\/51260362\/goodbye-grunt-work-oracles-ai-just-reclaimed-200-000-hours-for-doctors\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" rel=\"sponsored nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Goodbye, Grunt Work: Oracle&#039;s AI Just Reclaimed 200,000 Hours For Doctors;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Goodbye, Grunt Work&quot;,&quot;yHasCommerce&quot;:false}\" class=\"link \">Goodbye, Grunt Work: Oracle&#8217;s AI Just Reclaimed 200,000 Hours For Doctors<\/a> originally appeared on <a href=\"https:\/\/www.benzinga.com\" data-i13n=\"elm:affiliate_link;elmt:premonetized\" rel=\"sponsored nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Benzinga.com;elm:affiliate_link;elmt:premonetized;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;affiliate_link&quot;,&quot;yAffiliateService&quot;:&quot;premonetized&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Benzinga.com&quot;,&quot;yHasCommerce&quot;:false}\" class=\"link \">Benzinga.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Oracle Corp. shares surged Wednesday after the software giant reported better-than-expected third-quarter results and issued upbeat revenue guidance,&hellip;\n","protected":false},"author":2,"featured_media":387565,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[261],"tags":[291,177204,289,290,177203,84968,18,128689,19,17,4130,177205,82],"class_list":{"0":"post-387564","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-artificial-intelligence","8":"tag-ai","9":"tag-analyst-estimates","10":"tag-artificial-intelligence","11":"tag-artificialintelligence","12":"tag-atlanticare","13":"tag-earnings-per-share","14":"tag-eire","15":"tag-emergency-departments","16":"tag-ie","17":"tag-ireland","18":"tag-oracle-corp","19":"tag-oracle-health","20":"tag-technology"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116237728739897548","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/387564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=387564"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/387564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/387565"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=387564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=387564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=387564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}